These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15201683)

  • 1. Successful treatment of severe portopulmonary hypertension after liver transplantation by bosentan.
    Clift PF; Townend JN; Bramhall S; Isaac JL
    Transplantation; 2004 Jun; 77(11):1774-5. PubMed ID: 15201683
    [No Abstract]   [Full Text] [Related]  

  • 2. Portopulmonary hypertension associated with congenital absence of the portal vein treated with bosentan.
    Hino T; Hayashida A; Okahashi N; Wada N; Watanabe N; Obase K; Neishi Y; Kawamoto T; Okura H; Yoshida K
    Intern Med; 2009; 48(8):597-600. PubMed ID: 19367055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency.
    Barth F; Gerber PJ; Reichen J; Dufour JF; Nicod LP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1117-9. PubMed ID: 16957519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
    Sağ S; Yeşilbursa D; Güllülü S
    Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan therapy for portopulmonary hypertension.
    Hoeper MM; Halank M; Marx C; Hoeffken G; Seyfarth HJ; Schauer J; Niedermeyer J; Winkler J
    Eur Respir J; 2005 Mar; 25(3):502-8. PubMed ID: 15738295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-receptor antagonist treatment of portopulmonary hypertension.
    Hinterhuber L; Graziadei IW; Kähler CM; Jaschke W; Vogel W
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1039-42. PubMed ID: 15551258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of bosentan treatment for portopulmonary hypertension associated with syncope.
    Sato A; Maie K; Ohno Y; Yoshida T; Ito E; Tanabe Y; Aizawa Y
    Int Heart J; 2011; 52(4):243-5. PubMed ID: 21828952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
    Tapper EB; Knowles D; Heffron T; Lawrence EC; Csete M
    Transplant Proc; 2009 Jun; 41(5):1969-71. PubMed ID: 19545770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
    Kuntzen C; Gülberg V; Gerbes AL
    Gastroenterology; 2005 Jan; 128(1):164-8. PubMed ID: 15633133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis.
    Molnar C; Alber H; Colleselli D; Vogel W; Kähler CM
    Wien Klin Wochenschr; 2004 Sep; 116(17-18):627-30. PubMed ID: 15515882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
    Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
    Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
    Hoeper MM; Seyfarth HJ; Hoeffken G; Wirtz H; Spiekerkoetter E; Pletz MW; Welte T; Halank M
    Eur Respir J; 2007 Dec; 30(6):1096-102. PubMed ID: 17652314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Liver Transplant Complicated by Severe Portopulmonary Hypertension After an Initial Aborted Attempt: Case Report and Review of Treatment Options.
    Reid K; McQuillan P; Kadry Z; Janicki P; Bezinover D
    Exp Clin Transplant; 2017 Jun; 15(3):361-365. PubMed ID: 26101938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
    Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
    Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
    Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.
    Eriksson C; Gustavsson A; Kronvall T; Tysk C
    J Gastrointestin Liver Dis; 2011 Mar; 20(1):77-80. PubMed ID: 21451802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol.
    Laving A; Khanna A; Rubin L; Ing F; Dohil R; Lavine JE
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):466-8. PubMed ID: 16205516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.